Targeting the CaVα–CaVβ interaction yields an antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacyRajesh Khanna, May Khanna, Xiaofang Yang et al.|Pain|2019Cited by 44
Discovery and Optimization of a Series of Vinyl Sulfoximine-Based Analogues as Potent Nrf2 Activators for the Treatment of Multiple SclerosisYoowon Kim, Ki Duk Park|Journal of Medicinal Chemistry|2024Cited by 12